Drug Utilization Research (eBook)
1765 Seiten
Wiley (Verlag)
978-1-119-91167-8 (ISBN)
Towards a better understanding of how medicines are used in society
Drug Utilization Research (DUR) is a discipline which combines aspects of pharmacotherapy, epidemiology, and health services research into an interdisciplinary set of methods for analyzing and assessing the prescribing, dispensing and consumption of medicines. It combines both qualitative and quantitative approaches to facilitate the safe and effective use of pharmaceuticals. Drug Utilization Research: Methods and Applications provides a comprehensive introduction to this discipline, prepared by an international team of authors with broad experience in numerous fields. Now reorganized and updated to reflect the latest research and global challenges, it is an indispensable resource for understanding the use of pharmaceuticals.
Readers of the second edition of Drug Utilization Research will find:
- New chapters on methods, including more hands-on guidance on how to plan and conduct different types of drug utilization
- A section on specific applications in areas such as psychotropics, opioids, cancer drugs, antibacterials, and cardiovascular drugs
- A new section with case studies illustrating applications of DUR in different continents
- Detailed treatment of subjects including DUR and health policy, DUR in specific populations, and many more
Drug Utilization Research is ideal for epidemiologists, pharmacists, physicians, nurses and others interested in drug use and its outcomes.
Editors
Monique Elseviers, Björn Wettermark, Tanja Mueller, Ria Benk?, Marion Bennie, Katarina Gvozdanovi?, Mikael Hoffmann, Irina Iaru, Verica Ivanovska, Seán MacBride-Stewart, Elisabetta Poluzzi, Lisa Pont, Hege Salvesen Blix, Gabriel Sanfélix-Gimeno, Gisbert Selke, Katja Taxis, Ana Tomas Petrovi?, Indr? Tre?iokien?, Sabine Vogler
Towards a better understanding of how medicines are used in society Drug Utilization Research (DUR) is a discipline which combines aspects of pharmacotherapy, epidemiology, and health services research into an interdisciplinary set of methods for analyzing and assessing the prescribing, dispensing and consumption of medicines. It combines both qualitative and quantitative approaches to facilitate the safe and effective use of pharmaceuticals. Drug Utilization Research: Methods and Applications provides a comprehensive introduction to this discipline, prepared by an international team of authors with broad experience in numerous fields. Now reorganized and updated to reflect the latest research and global challenges, it is an indispensable resource for understanding the use of pharmaceuticals. Readers of the second edition of Drug Utilization Research will find: New chapters on methods, including more hands-on guidance on how to plan and conduct different types of drug utilizationA section on specific applications in areas such as psychotropics, opioids, cancer drugs, antibacterials, and cardiovascular drugsA new section with case studies illustrating applications of DUR in different continentsDetailed treatment of subjects including DUR and health policy, DUR in specific populations, and many more Drug Utilization Research is ideal for epidemiologists, pharmacists, physicians, nurses and others interested in drug use and its outcomes.
List of contributors
Mamoon A. Aldeyab
Department of Pharmacy
School of Applied Sciences
University of Huddersfield
Huddersfield
United Kingdom
Anna Birna Almarsdottir
WHO Collaborating Centre for Research and Training in the Patient Perspective on Medicines Use
Department of Pharmacy
Faculty of Health and Medical Sciences University of Copenhagen
Denmark
Morten Andersen
Department of Drug Design and Pharmacology
University of Copenhagen
Copenhagen
Denmark
Tuan Anh Nguyen
National Ageing Research Institute
Swinburne University
Melbourne
Australia
Ippazio Cosimo Antonazzo
Centre for Public Health Research (CESP)
University of Milan – Bicocca
Milan
Italy
Bernard Begauld
Faculty of Medicine
University of Bordeaux
France
Ria Benkő
Institute of Clinical Pharmacy
Faculty of Pharmacy
University of Szeged
Hungary
and
Emergency Department
Albert-Szent Györgyi Medical Centre
Central Pharmacy
University of Szeged
Hungary
Kathleen Bennett
Data Science Centre
School of Population Health
RCSI University of Medicine and Health Sciences
Dublin
Ireland
Marion Bennie
Strathclyde Institute of Pharmacy and Biomedical Sciences
University of Strathclyde
Glasgow
Scotland, UK
Hege Salvesen Blix
Antibiotic Resistance and Infection Prevention
Norwegian Institute of Public Health
OsloNorway
and
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Oslo
Norway
Jonathan Brett
St Vincent’s Clinical School
UNSW Medicine
UNSW Sydney
Australia
and
School of Population Health
Faculty of Medicine and Health
University of New South Wales
Sydney
Australia
Shawn Bugden
School of Pharmacy
Memorial University
Newfoundland
Canada
Johanita Burger
Medicine Usage in South Africa (MUSA)
North-West University
South Africa
Tatiana Chama Borges Luz
Rene Rachou Research Center
Oswaldo Cruz Foundation
Brazil
and
eHealth Institute
Department of Medicine and Optometry
Linnaeus University
Sweden
and
Department of Learning, Informatics, Management and Ethics (LIME)
Karolinska Institutet
Stockholm
Sweden
Antonio Clavenna
Laboratory of Child Health and Development Epidemiology
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
Milan
Italy
Samuel Coenen
Centre for General Practice
Department of Family Medicine and Population Health (FAMPOP) and Laboratory of Medical Microbiology
Vaccine and Infectious Disease Institute (VAXINFECTIO)
University of Antwerp – Campus Drie Eiken
Antwerp
Belgium
Luciane Cruz Lopes
University of Sorocaba
Sao Paulo
Brazil
Petra Denig
Department of Clinical Pharmacy and Pharmacology
University Medical Center Groningen
University of Groningen
Groningen
The Netherlands
Alexandra L. Dima
Health Technology Assessment in Primary Care and Mental Health (PRISMA)
Institut de Recerca Sant Joan de Deu
Barcelona
Spain
Louise C. Druedahl
Centre for Advanced Studies in Biomedical Innovation Law (CeBIL)
Faculty of Law
University of Copenhagen
Denmark
Carlos E. Durán
Department of Data Science and Biostatistics
University Medical Center
Utrecht
The Netherlands
Monique Elseviers
Department of Clinical Pharmacology
University of Ghent
Ghent
Belgium
and
Centre for Research and Innovation in Care (CRIC)
University of Antwerp
Antwerp
Belgium
Joseph Fadare
Department of Pharmacology and Therapeutics
Ekiti State University College of Medicine
Ado-Ekiti
Nigeria
Claudia Garcia Serpa Osorio-de-Castro
Department of Medicines Policies and Pharmaceutical Services
Sergio Arouca National School of Public Health
Oswaldo Cruz Foundation
Rio de Janeiro
Brazil
Kristina Garuoliene
Pharmacy and Pharmacology Center
Faculty of Medicine
Vilnius University
Lithuania
Cristina Mihaela Ghiciuc
Department of Pharmacology, Clinical Pharmacology and Algesiology
Faculty of Medicine
Grigore T. Popa University of Medicine and Pharmacy of Iasi
Romania
Catherine Goetzinger
National Health Observatory Luxembourg and Deep Digital Phenotyping Research Unit
Department of Precision Health
Luxembourg Institute of Health
Strassen
Luxembourg
and
Faculty of Science, Technology and Medicine
University of Luxembourg
Luxembourg
Katarina Gvozdanović
Pharmacoepidemiology Department
Andrija Štampar Teaching Institute of Public Health
ZagrebCroatia
Mohammadhossein Hajiebrahimi
Department of Pharmacy
Faculty of Pharmacy
Uppsala University
Sweden
Aleksi Hamina
Niuvanniemi Hospital
Kuopio
Finland
and
Norwegian Centre for Addiction Research (SERAF)
Institute of Clinical Medicine
University of Oslo
Oslo
Norway
Juan M. Hincapie-Castillo
Gillings School of Global Public Health
University of North Carolina
Chapel Hill, NC
USA
Mikael Hoffmann
The NEPI Foundation
Stockholm
Linköping
Sweden
and
Unit of Health Care Analysis
Department of Health, Medicine and Caring Sciences (HMV)
Linköping University
Linköping
Sweden
and
Department of Pharmacy
Faculty of Pharmacy
Uppsala University
Sweden
Dyfrig Hughes
Centre for Health Economics & Medicines Evaluation
Bangor University
United Kingdom
Irina Iaru
Department of Pharmacology, Physiology and Pathophysiology
Faculty of Pharmacy
Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca
Romania
Verica Ivanovska
World Health Organization
Geneva
Sofia Kälvemark Sporrong
Department of Pharmacy
Faculty of Pharmacy
Uppsala University
Sweden
and
Department of Pharmacy
Faculty of Health and Medical Sciences
University of Copenhagen
Copenhagen
Denmark
Anita Kotwani
Department of Pharmacology
Vallabhbhai Patel Chest Institute
University of Delhi
Delhi
India
Janet Krska
Clinical and Professional Pharmacy
Medway School of Pharmacy
United Kingdom
Amanj Kurdi
Strathclyde Institute of Pharmacy and Biomedical Sciences
University of Strathclyde
Glasgow
Scotland, UK
and
Department of Pharmacology and Toxicology
College of Pharmacy
Hawler Medical University
Erbil
Kurdistan Region Government
Iraq
and
Department of Clinical Pharmacy
College of Pharmacy
Al-Kitab University
Kirkuk
Iraq
and
School of Pharmacy
Sefako Makgatho Health Sciences University
Pretoria
South Africa
Irene Langner
AOK Research Institute (WIdO)
Berlin
Germany
George Leckie
Centre for Multilevel Modelling (CMM)
School of Education
University of Bristol
United Kingdom
Carl Llor
The Foundation University Institute for Primary Health Care
Research Jordi Gol i Gurina (IDIAPJGol), Via Roma Health Centre
Barcelona
Spain
Seán MacBride-Stewart
Pharmacy Services
NHS Greater Glasgow and Clyde
Glasgow
Scotland
Lorenzo G. Mantovani
Department of Statistics
School of Medicine
University of Milan
Italy
Maria Matuz
Institute of Clinical Pharmacy
Faculty of Pharmacy
University of Szeged
Hungary
Giampiero Mazzaglia
Centre for Public Health Research (CESP)
School of Medicine and Surgery
University of Milan – Bicocca
Milan
Italy
Stuart McTaggart
Public Health Scotland
Edinburgh
United Kingdom
Juan Merlo
Unit for Social Epidemiology
Department of Clinical Sciences
Centre for Primary Health Care Research
Faculty of Medicine
Lund University
Malmo
Sweden
Peter Mol
Medicines Evaluation Board
Utrecth
The Netherlands
and
Department of Clinical Pharmacy and Pharmacology
University Medical Centre Groningen
University of Groningen
The Netherlands
Aminath Moomina
Medicines and Goods Therapeutic Division
Food and Drug Authority
Republic of Maldives
Tanja Mueller
Strathclyde Institute of Pharmacy and Biomedical Sciences
University of Strathclyde
Glasgow
Scotland
Urska Nabergoj-Makovec
Department of Social Pharmacy
Faculty of Pharmacy
University of Ljubljana
Ljubljana
Slovenia
Marmar Nekoro
Swedish Knowledge Centre on Pharmaceuticals in the Environment
Swedish Medical Products Agency
P.O Box 26,...
| Erscheint lt. Verlag | 13.9.2024 |
|---|---|
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie ► Gesundheitsfachberufe |
| Medizin / Pharmazie ► Medizinische Fachgebiete | |
| Schlagworte | cardiometabolic drugs • medical treatment • pain relieving medication • Pharmaceutical development • pharmaceutical intervention • pharmacoepidemiology • pharmacology • psychotropics • Qualitative Analysis • Quantitative Analysis |
| ISBN-10 | 1-119-91167-2 / 1119911672 |
| ISBN-13 | 978-1-119-91167-8 / 9781119911678 |
| Haben Sie eine Frage zum Produkt? |
EPUB (Ohne DRM)Digital Rights Management: ohne DRM
Dieses eBook enthält kein DRM oder Kopierschutz. Eine Weitergabe an Dritte ist jedoch rechtlich nicht zulässig, weil Sie beim Kauf nur die Rechte an der persönlichen Nutzung erwerben.
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür die kostenlose Software Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür eine kostenlose App.
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
